Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06872905 · ClinicalTrials.gov registry record
Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used in Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) to Treat Aortoiliac Occlusive Disease
A clinical trial of Aortoiliac Occlusive Disease, sponsored by W.L.Gore & Associates.
- Recruiting
- Registry status
- 158
- Enrollment target
- 18
- Study locations
NCT06872905 is a study of Aortoiliac Occlusive Disease that is actively recruiting participants, run by W.L.Gore & Associates. The registered enrollment target is 158 participants. The trial reports 18 study locations across 11 states.
The verdict
NCT06872905, a study of Aortoiliac Occlusive Disease, is actively recruiting participants, sponsored by W.L.Gore & Associates.
- RECRUITING
- Registry status
- 158 participants
- Enrollment target
- 18
- Study locations
Study Summary
The study will assess the safety and effectiveness of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis ("VBX Device" or also referred to as "VBX Stent Graft") in a post approval setting and evaluate the quality of the use in covered endovascular reconstruction of the aortic bifurcation (CERAB) to treat Aortoiliac Occlusive Disease (AIOD).
Conditions Studied
Interventions
- DEVICE GORE VIABAHN® VBX Balloon Expandable Endoprosthesis (VBX)
Study Locations (18)
Other
- Azienda Ospedaliero-Universitaria di Padova - Padua
- Ospedale di Circolo e Fondazione Macchi - Varese
- Amsterdam UMC Research BV - Amsterdam
- Franciscus - Rotterdam
- Hospital General Universitario de Alicante - Alicante
- Greater Glasgow Health Board - Glasgow
New Jersey
- Cooper University Hospital - Camden
- Rutgers - New Brunswick
New York
- Research Foundation SUNY Buffalo - Buffalo
- Mount Sinai Medical Center - New York
California
- University of California - Fresno
Minnesota
- Mayo Clinic Rochester - Rochester
Ohio
- Ohio State University Medical Center - Columbus
Pennsylvania
- University Of Pennsylvania - Philadelphia
Tennessee
- Wellmont Holston Valley Medical Center - Kingsport
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 158 participants |
| Start Date | 2025-05-30 |
| Est. Completion | 2027-08-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06872905
The ClinicalTrials.gov registry entry for NCT06872905 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 158 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is W.L.Gore & Associates, which has 53 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Aortoiliac Occlusive Disease appearing as the primary indexed condition, and to 1 intervention - of which GORE VIABAHN® VBX Balloon Expandable Endoprosthesis (VBX) is the first listed.
NCT06872905 reports 18 study locations spanning 11 distinct geographic areas - top geographies include Other, New Jersey, New York.
Frequently Asked Questions
What is clinical trial NCT06872905 about?
NCT06872905 is a clinical study titled "Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used in Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) to Treat Aortoiliac Occlusive Disease". The study will assess the safety and effectiveness of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis ("VBX Device" or also referred to as "VBX Stent Graft") in a post approval setting and evaluate the quality of the use in covered endovascular reconstruction of the aortic bifurcation (CERA...
What is the current status of trial NCT06872905?
This trial is currently recruiting. The enrollment target is 158 participants. The study started on 2025-05-30. Estimated completion is 2027-08-16.
What conditions does trial NCT06872905 study?
This clinical trial studies the following conditions: Aortoiliac Occlusive Disease.
What interventions are being tested in trial NCT06872905?
The interventions under investigation include: GORE VIABAHN® VBX Balloon Expandable Endoprosthesis (VBX) (DEVICE).
Who is sponsoring clinical trial NCT06872905?
This trial is sponsored by W.L.Gore & Associates, which has 53 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06872905 being conducted?
This trial has 18 study locations across California, Minnesota, New Jersey, New York, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aortoiliac Occlusive Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Liposomal Bupivacaine/Bupivacaine in Rectus Sheath Blocks Versus Ropivacaine in Rectus Sheath Blocks And Catheters
RECRUITING · Phase 4
-
The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.